| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/13/2002 | EP1178807A2 Use of antiprogestagens in combined therapy |
| 02/13/2002 | EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
| 02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 02/13/2002 | EP0699069B1 Endothelin receptor antagonists |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335772A Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
| 02/13/2002 | CN1335317A Process for producing pyrazolo [4,3-d] pyrimidine-7-ketonic compound and its intermediate |
| 02/13/2002 | CN1335177A Yang-strengthening and kidney-invigorating medicine and is prepn |
| 02/13/2002 | CN1335176A Chinaroot greenbrier rhizome extract and its prepn process |
| 02/13/2002 | CN1335171A Gynopathy treating Chinese medicine with functions of diminishing inflammation and eliminating spot and its prepn |
| 02/13/2002 | CN1335144A Chinese medicine plaster for treating mastoproliferation and its prepn |
| 02/13/2002 | CN1335143A Chinese medicine for treating mastoproliferation |
| 02/13/2002 | CN1335129A Gynopathy treating medicine |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 02/07/2002 | WO2002010171A1 Crystalline therapeutic agent |
| 02/07/2002 | WO2002010169A1 Piperazine derivatives |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002009716A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009706A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | WO2002009705A2 Agonist of follicle stimulating hormone activity |
| 02/07/2002 | WO2002009703A1 Method for treating cryptorchidism |
| 02/07/2002 | WO2002009701A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | WO2002009690A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001010425A3 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 02/07/2002 | US20020016532 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| 02/07/2002 | US20020016365 Nonsteroidal gestagens |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 02/07/2002 | US20020016354 Treatment of respiratory diseases, convulsions, vascular disorders, renal disorders, urinary disorders, Alzheimer's disease, dysmenorrhea, narcolepsy |
| 02/07/2002 | US20020016342 Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016318 Methods of treating breast disorders |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | CA2426297A1 Agonist of follicle stimulating hormone activity |
| 02/07/2002 | CA2425889A1 Agonists of follicle stimulating hormone activity |
| 02/07/2002 | CA2418115A1 Imidazole derivatives |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417533A1 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | CA2417277A1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2416978A1 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2414623A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis |
| 02/07/2002 | CA2385908A1 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/06/2002 | EP1178047A1 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 02/06/2002 | EP1177791A2 Use of glycogen phosphorylase inhibitors to inhibit tumor growth |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177205A1 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1177190A2 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP1176976A1 Gonadotrophins |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1001775B1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 02/06/2002 | EP0971917B1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 02/06/2002 | EP0938330B1 Use of lh-rh antagonists as diagnostic agent |
| 02/06/2002 | EP0771198B1 Dihydro-2,3-benzodiazepine derivatives |
| 02/06/2002 | EP0730448B1 Use of nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor for the manufacture of medicaments for the treatment of uterine contractility disorders |
| 02/06/2002 | CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists |
| 02/06/2002 | CN1334741A 肽的用途 Use of a peptide |
| 02/06/2002 | CN1334736A Modulation of immune response by ribavirin |
| 02/06/2002 | CN1334734A Triphasic oral contraceptive |
| 02/06/2002 | CN1334115A Medicinal liquor for treating sexual disfunction and its preparing process |
| 02/06/2002 | CN1334114A Chinese medicine for treating mastoplasia |
| 02/06/2002 | CN1334082A Chinese-medical suppository for treating vaginal looseness |
| 02/05/2002 | US6344468 Substituted isoindolones and their use as cyclic GMP modulators in medicaments |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344459 Treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344455 Treating cancer, atherosclerosis, restenosis, endometriosis, and psoriasis |
| 02/05/2002 | US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents. |
| 02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008231A2 Biologically active macrolides, compositions, and uses thereof |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008212A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |